Small firm, global reach Wombat Capital is a small cross-border advisory with offices in New York and Paris and a focus on the lower middle market—a niche ripe for partnerships with mid-size buyers and growth-focused investors seeking cross-border expertise and tailored deal execution.

Life sciences tilt Industry focus on Life Sciences and Healthcare suggests opportunities to engage pharma, biotech, medical devices, and healthcare IT clients seeking M&A, financing, or strategic advisory, especially for cross-border transactions and complex valuation needs.

Financing capabilities Offering debt and equity financing along with valuation and fairness opinions positions Wombat Capital as a one-stop shop for financing rounds and strategic investments, enabling cross-sell to clients requiring capital structuring and investor outreach.

Boutique leverage As a small team with high specialization, there is potential to develop targeted, high-margin advisory and exclusive deal sourcing with mid-market clients who value senior attention, rapid execution, and bespoke advisory services.

Growth via partnerships With FINRA/SIPC registered status and cross-border capabilities, there are commercial development opportunities to partner with larger advisory firms, private equity groups, and corporate clients looking for international deal experience and access to a New York–Paris corridor.